newsfilter
← Latest News
GlobeNewswire·

Applied Molecular Transport Provides Strategy Update

Company streamlines to prioritize resources on key proprietary clinical programs, including plans to advance AMT-101 into Phase 3 for chronic pouchitis Three Phase 2 top-line readouts for oral AMT-101 in ulcerative colitis (UC) and rheumatoid arth